Axillary lymph node uptake of technetium-99m-MDP.
We sought to determine the frequency and significance of axillary lymph node visualization on bone scans performed with diphosphonates.


METHODS
Consecutive 99mTc-methylene diphosphonate (99mTc-MDP) bone scans (2435) were inspected for axillary soft-tissue uptake. In positive cases, the results of physical examination, correlative imaging studies and serial bone scans were recorded, as was the site of venipuncture.


RESULTS
Forty-eight studies (2%) showed axillary uptake ipsilateral to the injection site. Extravasation of tracer, documented by focal activity near the injection site, was present in every case. There was no association with axillary adenopathy, mass, induration or radiographically visible calcification. On some images, foci adjacent to the axilla were superimposed on the rib, scapula, or humerus. The bone-to-background ratio was frequently reduced; repeat imaging after 1-2 hr usually improved osseous detail.


CONCLUSIONS
Ipsilateral axillary lymph node visualization due to extravasation of 99mTc-MDP is frequently associated with additional foci superimposed on osseous structures simulating pathology. Delayed skeletal uptake is common in such cases and necessitates a greater time interval between injection and imaging.
Ongseng
F
F
Department of Radiology, Beth Israel Medical Center, New York, New York 10003, USA.
Goldfarb
C R
CR
Finestone
H
H
D001365:Axilla; D001842:Bone and Bones / Q000000981:diagnostic imaging*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000000981:diagnostic imaging / Q000453:epidemiology; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D011446:Prospective Studies; D011877:Radionuclide Imaging; D013669:Technetium Tc 99m Medronate
D013669:Technetium Tc 99m Medronate